CHICAGO – "Chicagohenge" is set to begin this week as spring is finally upon us.Chicagohenge is a spectacle that occurs
A volcano on Flores Island in Indonesia woke up island residents early Friday when the latest eruptive episode sent ash
TREMFYA® is the only IL-23i to demonstrate clinical remission and endoscopic response, both at one year, with a fully subcutaneous
SAN FRANCISCO, March 20, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its
LOS ANGELES, March 20, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology
A case study on how a leading European dermatology company sought regulatory intelligence support to navigate the CDSCO framework. The
VICTORIA, BC, March 20, 2025 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company
BOSTON, IL, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Boston, MA – March 20, 2025 – Clean Power Research® and
Trellix achieved great success in AV-Comparatives’ Enterprise Main-Test Series of 2024 INNSBRUCK, TIROL, AUSTRIA, March 20, 2025 /EINPresswire.com/ -- Trellix achieved
Peer-to-peer digital content sharing for construction and building professionals SUNDRE, ALBERTA, CANADA, March 20, 2025 /EINPresswire.com/ -- Since its establishment in